Brief: Hoth Therapeutics Issues Update- HT-001, HT-KIT, VA Obesity Program Drive Strongest Position in Company History
16/09/2025 14:05
Sept 16 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS ISSUES SHAREHOLDER UPDATE: HT-001, HT-KIT, EXPANDED TREASURY RESERVE STRATEGY, AND VA OBESITY PROGRAM DRIVE STRONGEST POSITION IN COMPANY HISTORY Source text: ID:nPn5J02r3a Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology